Olympus is once again embroiled in controversy following the discovery of emails that show the company pushed up the price of duodenoscopes after the deadly Carbapenem-resistant Enterobacteria outbreak at UCLA’s Ronald Reagan Medical Center, which left three dead.
Olympus unveiled the VISERA 4K UHD System.
Cairn Diagnostics launched the 13C-Spirulina Gastric Emptying Breath Test.
Zacks Investment Research upgraded EndoChoice Holdings from a “hold” rating to a “buy” rating.
Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand ‘Actibile’ from drug firm Albert David.
R. Gregory Scheible, MD, is the first physician Indiana to implant Apollo Endosurgery’s Orbera intragastric balloon in a patient using a non-surgical procedure.
Clinical Genomics recently closed a $15 million series A financing round.
GI Dynamics appointed Scott Schorer as president and CEO, effective immediately.
More articles on GI/endoscopy:
5 most read GI/endoscopy stories
What ulcerative colitis patients most want to know from their physicians
GI Dynamics names Scott Schorer CEO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.